COVID-19 Vaccine Now Available for Ages 5-11 at Cohen Children’s Medical Center

Children ages 5-11 and their parents are one step closer to ending the pandemic after Cohen Children’s Medical Center today began offering Pfizer-BioNTech’s kid-size coronavirus disease 2019 (COVID-19) vaccine. The Center for Disease Control and Prevention signed off on the latest age group to be vaccinated – representing 28 million Americans – and clearing the way for the families of seven youngsters to be the first at Northwell Health.

The patients and their parents, many of whom are physicians at the hospital, were greeted by Charles Schleien, MD, senior vice president and chair of pediatrics at Northwell Health and Cohen Children’s. Noting that this vaccination was a big step toward protecting those who are eligible, Dr. Schleien said, “In New York, six in 10 kids who are 12-and-over are already vaccinated. We need to get that number higher – and starting today, we need to chip away at vaccinating the newest group of eligible children. The vaccine is safe. It works – and it will be the way we successfully lower COVID stats across the region, nation and world.”

Sophia Jan, MD, chief of general pediatrics at Cohen Children’s, was on hand to vaccinate the youngsters and offer her support to their parents. “Being vaccinated will make it so much easier for our youngsters to get back to their normal lives,” said Dr. Jan. “Not only will they be able to get back to school and enjoy the holidays, but the important things – like hugging their parents and visiting their grandparents – we can start thinking about these things again.”

When interviewed as a group by a roomful of reporters, the newly vaccinated children all agreed that a moment of discomfort was well worth the relief of staying virus free. “Maybe one day we can go to school without masks,” they said.

In an effort to provide vaccinations to this newest eligible group, Northwell Health has established vaccination pods in Manhattan, Queens, Long Island and Westchester County. Locations and hours are:

  • Nassau County: (1 Marcus Ave, New Hyde Park, NY) Nov. 7 & 14, 9 a.m.-5 p.m.
  • Suffolk County: (5181 Sunrise Highway, Bohemia, NY) Nov. 6 & 13, 9 a.m.-5 p.m.
  • Suffolk County: (284 Pulaski Road, Greenlawn, NY) Nov. 11, 8 a.m.-8 p.m.; Nov. 18, Noon-8 p.m.
  • Suffolk County: (4 West 2nd Street, Riverhead, NY) Nov. 7 & 14, 9 a.m.-5 p.m.
  • Manhattan: (200 West 13th Street, New York, NY) Nov. 10, 3-7 p.m.; Nov. 13, 10 a.m.-3 p.m.
  • Queens: (95-25 Queens Blvd., Rego Park, NY) Nov. 6 & 13, 9 a.m.-9 p.m.
  • Westchester County: (480 North Bedford Road, Chappaqua, NY) Nov. 7 & 14, 9 a.m.-5 p.m.

To schedule a vaccine appointment, call (844) 919-VACC for the most up-to-date availability or go to:




Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The AGENT DCB is available in Europe, parts of Asia Pacific and Latin America for the treatment of patients with ISR and previously untreated small vessel coronary disease. Boston Scientific plans to launch the technology in the U.S. in the coming months.
Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy